First Light Asset Management as of June 30, 2016
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 65 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 7.6 | $16M | 2.0M | 8.04 | |
| Akorn | 6.9 | $15M | 526k | 28.49 | |
| AtriCure (ATRC) | 6.0 | $13M | 923k | 14.13 | |
| LHC | 4.5 | $9.8M | 227k | 43.28 | |
| Enzo Biochem (ENZB) | 3.8 | $8.1M | 1.4M | 5.97 | |
| Harvard Bioscience (HBIO) | 3.6 | $7.8M | 2.7M | 2.86 | |
| Entellus Medical Cm | 3.4 | $7.2M | 396k | 18.27 | |
| Teligent | 3.3 | $7.2M | 1.0M | 7.14 | |
| Oxford Immunotec Global | 2.9 | $6.3M | 701k | 9.00 | |
| Amedisys (AMED) | 2.8 | $6.1M | 121k | 50.48 | |
| NxStage Medical | 2.5 | $5.5M | 254k | 21.68 | |
| Orthofix International Nv Com Stk | 2.5 | $5.5M | 130k | 42.40 | |
| LeMaitre Vascular (LMAT) | 2.5 | $5.5M | 386k | 14.27 | |
| HealthStream (HSTM) | 2.5 | $5.4M | 205k | 26.52 | |
| BioScrip | 2.5 | $5.3M | 2.1M | 2.55 | |
| Model N (MODN) | 2.5 | $5.3M | 397k | 13.35 | |
| Ligand Pharmaceuticals In (LGND) | 2.3 | $5.0M | 42k | 119.28 | |
| Envision Healthcare Hlds | 2.3 | $4.9M | 192k | 25.37 | |
| K2m Group Holdings | 2.0 | $4.4M | 282k | 15.52 | |
| Aratana Therapeutics | 2.0 | $4.3M | 685k | 6.32 | |
| Medicines Company | 2.0 | $4.2M | 126k | 33.63 | |
| Biotelemetry | 1.9 | $4.2M | 255k | 16.30 | |
| Ldr Hldg | 1.8 | $3.9M | 106k | 36.95 | |
| Spectranetics Corporation | 1.7 | $3.7M | 198k | 18.71 | |
| RTI Biologics | 1.6 | $3.5M | 987k | 3.59 | |
| Physicians Realty Trust | 1.5 | $3.3M | 156k | 21.01 | |
| Endologix | 1.5 | $3.2M | 258k | 12.46 | |
| Cynapsus Therapeutics | 1.5 | $3.2M | 189k | 16.75 | |
| Bluebird Bio | 1.3 | $2.9M | 67k | 43.29 | |
| Veracyte (VCYT) | 1.3 | $2.7M | 546k | 5.03 | |
| Bio-techne Corporation (TECH) | 1.3 | $2.7M | 24k | 112.77 | |
| Alkermes (ALKS) | 1.2 | $2.7M | 62k | 43.23 | |
| Tearlab Corp | 1.1 | $2.4M | 3.8M | 0.64 | |
| Immunomedics | 1.1 | $2.3M | 988k | 2.32 | |
| Streamline Health Solutions | 1.0 | $2.2M | 1.8M | 1.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $2.1M | 24k | 86.01 | |
| Array BioPharma | 0.9 | $2.0M | 555k | 3.56 | |
| Cepheid | 0.9 | $1.9M | 62k | 30.75 | |
| Quidel Corporation | 0.7 | $1.5M | 84k | 17.86 | |
| Nanostring Technologies (NSTGQ) | 0.7 | $1.5M | 119k | 12.60 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $1.4M | 19k | 77.77 | |
| Aetna | 0.3 | $637k | 5.2k | 122.15 | |
| Humana (HUM) | 0.3 | $637k | 3.5k | 179.94 | |
| Bristol Myers Squibb (BMY) | 0.3 | $610k | 8.3k | 73.58 | |
| Becton, Dickinson and (BDX) | 0.3 | $576k | 3.4k | 169.66 | |
| Anthem (ELV) | 0.2 | $538k | 4.1k | 131.38 | |
| Novartis (NVS) | 0.2 | $501k | 6.1k | 82.54 | |
| Allergan | 0.2 | $470k | 2.0k | 230.96 | |
| Johnson & Johnson (JNJ) | 0.2 | $463k | 3.8k | 121.20 | |
| Agile Therapeutics | 0.2 | $454k | 60k | 7.60 | |
| Eli Lilly & Co. (LLY) | 0.2 | $433k | 5.5k | 78.80 | |
| Celgene Corporation | 0.2 | $422k | 4.3k | 98.60 | |
| IRIDEX Corporation (IRIX) | 0.2 | $429k | 29k | 14.79 | |
| Mylan Nv | 0.2 | $423k | 9.8k | 43.27 | |
| Steris | 0.2 | $435k | 6.3k | 68.72 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $405k | 3.8k | 106.02 | |
| Merck & Co (MRK) | 0.2 | $381k | 6.6k | 57.64 | |
| Pfizer (PFE) | 0.2 | $370k | 11k | 35.17 | |
| AstraZeneca | 0.2 | $343k | 11k | 30.19 | |
| Amgen (AMGN) | 0.2 | $355k | 2.3k | 152.36 | |
| St. Jude Medical | 0.1 | $305k | 3.9k | 77.99 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $238k | 5.7k | 41.90 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $227k | 5.1k | 44.34 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $240k | 1.7k | 143.28 | |
| Myriad Genetics (MYGN) | 0.1 | $239k | 7.8k | 30.56 |
